Pharma and Biotech
Holding(s) in Company | 12-Sep-2023 | 07:00 | RNS |
Results of Shareholder’s General Meeting | 05-Sep-2023 | 12:34 | RNS |
Change of registry address notification | 01-Sep-2023 | 07:30 | RNS |
30 June 2023 Preliminary Financial Report | 31-Aug-2023 | 08:44 | RNS |
Share Purchase Plan Closed | 30-Aug-2023 | 08:30 | RNS |
SPP – Extension of Closing Date | 15-Aug-2023 | 07:29 | RNS |
Positive Pre-clinical Trial Results on CimetrA... | 14-Aug-2023 | 07:00 | RNS |
Dispatch of General Meeting Documents | 04-Aug-2023 | 09:10 | RNS |
Australian Prospectus & Share Purchase Plan | 03-Aug-2023 | 14:23 | RNS |
Application for Admission to Trading | 02-Aug-2023 | 10:25 | RNS |
MGC Pharma Launches Share Purchase Plan | 01-Aug-2023 | 08:56 | RNS |
Permission for first import of Psilocybin | 31-Jul-2023 | 07:00 | RNS |
Resignation of Joint Company Secretary | 28-Jul-2023 | 09:05 | RNS |
June 2023 Quarter Activity Report and Cash Flow | 28-Jul-2023 | 08:00 | RNS |
Holding(s) in Company | 21-Jul-2023 | 10:56 | RNS |
Currency | UK Pounds |
Share Price | 21.29p |
Change Today | -0.21p |
% Change | -1.00 % |
52 Week High | 550.00 |
52 Week Low | 18.00 |
Volume | 153 |
Shares Issued | 3,286.48m |
Market Cap | £699.55m |
RiskGrade | 1,233 |
Value |
---|
Value |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
10:37 | 29 @ 20.00p |
10:12 | 88 @ 22.52p |
10:08 | 35 @ 20.01p |
08:42 | 1 @ 20.00p |
You are here: research